{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:07Z","timestamp":1786118827725,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/cad.0b013e3282ffd6a4","type":"journal-article","created":{"date-parts":[[2008,5,22]],"date-time":"2008-05-22T03:04:54Z","timestamp":1211425494000},"page":"621-630","source":"Crossref","is-referenced-by-count":18,"title":["The effects of sulfur-containing compounds and gemcitabine on the binding of cisplatin to plasma proteins and DNA determined by inductively coupled plasma mass spectrometry and high performance liquid chromatography\u2013inductively coupled plasma mass spectrometry"],"prefix":"10.1097","volume":"19","author":[{"given":"Elke E.M.","family":"Brouwers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alwin D.R.","family":"Huitema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.M.","family":"Schellens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos H.","family":"Beijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210203","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1039\/b212797k","article-title":"Studies of cisplatin and hemoglobin interactions using nanospray mass spectrometry and liquid chromatography with inductively-coupled plasma mass spectrometry","volume":"128","author":"Mandal","year":"2003","journal-title":"Analyst"},{"key":"R2-9-20210203","first-page":"189","article-title":"Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity","volume":"17","author":"Calvert","year":"1993","journal-title":"Cancer Surv"},{"key":"R3-9-20210203","first-page":"1205","article-title":"Clinical pharmacokinetics of oxaliplatin: a critical review","volume":"6","author":"Graham","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ijc.21919","article-title":"Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III\/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT)","volume":"119","author":"Hoebers","year":"2006","journal-title":"Int J Cancer"},{"key":"R5-9-20210203","first-page":"1426","article-title":"Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection","volume":"43","author":"Howell","year":"1983","journal-title":"Cancer Res"},{"key":"R6-9-20210203","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1200\/JCO.1984.2.12.1321","article-title":"Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity","volume":"2","author":"Markman","year":"1984","journal-title":"J Clin Oncol"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1023\/A:1008296202198","article-title":"Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease","volume":"8","author":"Van Rijswijk","year":"1997","journal-title":"Ann Oncol"},{"key":"R8-9-20210203","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archotol.1997.01900090094014","article-title":"Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer","volume":"123","author":"Madasu","year":"1997","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00686237","article-title":"Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer","volume":"25","author":"Di Re","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"R10-9-20210203","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1124\/jpet.105.087601","article-title":"Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels","volume":"314","author":"Dickey","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R11-9-20210203","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.571145","article-title":"Thiourea reverses cross-links and restores biological activity in DNA treated with dichlorodiaminoplatinum (II)","volume":"204","author":"Filipski","year":"1979","journal-title":"Science"},{"key":"R13-9-20210203","first-page":"3526","article-title":"Randomized phase I clinical and pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and gemcitabine in patients with advanced non-small cell lung cancer","volume":"9","author":"Crul","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R14-9-20210203","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jms.1087","article-title":"Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate","volume":"41","author":"Brouwers","year":"2006","journal-title":"J Mass Spectrom"},{"key":"R15-9-20210203","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00686008","article-title":"Influence of glutathione administration on the disposition of free and total platinum in patients after administration of cisplatin","volume":"29","author":"Leone","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"R16-9-20210203","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/BF00558131","article-title":"The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage","volume":"37","author":"Prescott","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"R17-9-20210203","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1172\/JCI102604","article-title":"The volume of distribution of sodium thiosulfate as a measure of the extracellular fluid space","volume":"31","author":"Cardozo","year":"1952","journal-title":"J Clin Invest"},{"key":"R18-9-20210203","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0168-8278(97)80426-6","article-title":"Glutathione kinetics in normal man and in patients with liver cirrhosis","volume":"26","author":"Bianchi","year":"1997","journal-title":"J Hepatol"},{"key":"R19-9-20210203","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/01.cad.0000176507.78928.4d","article-title":"Phase I clinical and pharmacologic study of a 2-weekly administration of cisplatin and gemcitabine in patients with advanced non-small cell lung cancer","volume":"16","author":"Rademaker-Lakhai","year":"2005","journal-title":"Anticancer Drugs"},{"key":"R20-9-20210203","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/sj.bjc.6602850","article-title":"Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours","volume":"93","author":"Siegel-Lakhai","year":"2005","journal-title":"Br J Cancer"},{"key":"R21-9-20210203","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/abio.1999.4302","article-title":"32P-postlabeling assay for the quantification of the major platinum-DNA adducts","volume":"275","author":"Pluim","year":"1999","journal-title":"Anal Biochem"},{"key":"R22-9-20210203","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/bjc.1995.102","article-title":"Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair","volume":"71","author":"Ma","year":"1995","journal-title":"Br J Cancer"},{"key":"R23-9-20210203","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/nar\/23.8.1300","article-title":"Detection of platinum-DNA adducts by 32P-postlabelling","volume":"23","author":"Blommaert","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"R24-9-20210203","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s002160100740","article-title":"HPIC-UV-ICP-SFMS study of the interaction of cisplatin with guanosine monophosphate","volume":"370","author":"Hann","year":"2001","journal-title":"Fresenius J Anal Chem"},{"key":"R25-9-20210203","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1023\/A:1006975720999","article-title":"The reaction of sulphur and nitrogen nucleophiles with [Pt(dien)Cl]+","volume":"24","author":"Hay","year":"1999","journal-title":"Transition Met Chem"},{"key":"R26-9-20210203","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/clinchem\/32.4.641","article-title":"Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding","volume":"32","author":"Elferink","year":"1986","journal-title":"Clin Chem"},{"key":"R27-9-20210203","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1177\/153537020623101009","article-title":"Kinetics of cisplatin and its monohydrated complex with sulfur-containing compounds designed for local otoprotective administration","volume":"231","author":"Videhult","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"R28-9-20210203","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1073\/pnas.0737293100","article-title":"New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA","volume":"100","author":"Reedijk","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-9-20210203","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/jnci\/81.20.1552","article-title":"Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin","volume":"81","author":"Goel","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"R30-9-20210203","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/BF00686189","article-title":"Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity","volume":"36","author":"Nagai","year":"1995","journal-title":"Cancer Chemother Pharmacol"},{"key":"R31-9-20210203","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/carcin\/16.9.2099","article-title":"Uptake and distribution of N-acetylcysteine in mice: tissue-specific effects on glutathione concentrations","volume":"16","author":"McLellan","year":"1995","journal-title":"Carcinogenesis"},{"key":"R32-9-20210203","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1021\/cr980422f","article-title":"Why does cisplatin reach guanine-N7 with competing S-donor ligands available in the cell?","volume":"99","author":"Reedijk","year":"1999","journal-title":"Chem Rev"},{"key":"R33-9-20210203","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1039\/a709282b","article-title":"Interconversion between S- and N-bound L-methionine adducts of Pt(dien)2+ (dien=diethylenetriamine) via dien ring-opened intermediates","volume":"9","author":"Chen","year":"1998","journal-title":"J Chem Soc, Dalton Trans"},{"key":"R34-9-20210203","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/1040-8428(90)90010-P","article-title":"Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate","volume":"10","author":"Gandara","year":"1990","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e3282ffd6a4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:05:08Z","timestamp":1786035908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200807000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e3282ffd6a4","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}